24 November 2017
News and Views
Links and Services
A study in the latest issue of Gut investigates coronary artery disease and cardiovascular outcomes in non-alcoholic fatty liver disease.
Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome and
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors